September 2nd 2025, 9:00pm
Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer detection safe and valuable.
September 2nd 2025, 8:00pm
CURE spoke with Dr. Ryan Kahn of Miami Cancer Institute for Ovarian Cancer Awareness Month.
September 2nd 2025, 7:00pm
In August 2025, the FDA approved various anti-cancer treatments across a range of disease types, such as colorectal, lung cancer and brain cancer.
September 2nd 2025, 5:00pm
For me, standing up to cancer means honoring my wife’s melanoma journey by raising awareness, supporting early detection and research.
September 2nd 2025, 4:00pm
The FDA has approved the NDA for Camcevi ETM for the treatment of advanced prostate cancer.
September 2nd 2025, 3:00pm
The FDA approved Bildyos and Bilprevda as biosimilars to Prolia and Xgeva, expanding bone care options for osteoporosis, cancer and more.
September 2nd 2025, 1:00pm
Elahere, validated in a phase 3 trial, is FDA-approved and offers the first major advancement for platinum-resistant ovarian cancer in decades.
September 1st 2025, 3:00pm
In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer.
September 1st 2025, 1:00pm
Clara Mae Cirk, a 30-year-old diagnosed with stage 4 lung cancer, shares how cancer has reshaped her perspective on strength and self-care.
August 31st 2025, 6:00pm
Cancer taught me to embrace life’s seasons, finding hope, joy, and gratitude in each chapter, no matter the struggles I face.
Top Breast Cancer Stories from October 2025
New Book Spotlights Cancer in Early Adulthood
Top Gastrointestinal Cancer News: October 2025
Hairy Cell Leukemia Experts Impart Advice on Care and Support